Adverum Biotechnologies, Inc. (ADVM)
4.36
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Adverum Biotechnologies Total Liabilities (Quarterly) : 128.05M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 128.05M |
| June 30, 2025 | 116.40M |
| March 31, 2025 | 111.23M |
| December 31, 2024 | 109.13M |
| September 30, 2024 | 90.26M |
| June 30, 2024 | 85.77M |
| March 31, 2024 | 85.54M |
| December 31, 2023 | 88.55M |
| September 30, 2023 | 94.06M |
| June 30, 2023 | 110.27M |
| March 31, 2023 | 117.82M |
| December 31, 2022 | 126.85M |
| September 30, 2022 | 124.02M |
| June 30, 2022 | 130.83M |
| March 31, 2022 | 124.44M |
| December 31, 2021 | 123.54M |
| September 30, 2021 | 144.58M |
| June 30, 2021 | 147.00M |
| March 31, 2021 | 46.73M |
| December 31, 2020 | 48.22M |
| September 30, 2020 | 43.00M |
| June 30, 2020 | 48.61M |
| March 31, 2020 | 44.65M |
| December 31, 2019 | 47.77M |
| Date | Value |
|---|---|
| September 30, 2019 | 41.31M |
| June 30, 2019 | 32.14M |
| March 31, 2019 | 32.90M |
| December 31, 2018 | 12.33M |
| September 30, 2018 | 10.35M |
| June 30, 2018 | 13.14M |
| March 31, 2018 | 11.12M |
| December 31, 2017 | 17.88M |
| September 30, 2017 | 17.22M |
| June 30, 2017 | 16.40M |
| March 31, 2017 | 20.55M |
| December 31, 2016 | 18.98M |
| September 30, 2016 | 20.34M |
| June 30, 2016 | 16.69M |
| March 31, 2016 | 11.37M |
| December 31, 2015 | 11.73M |
| September 30, 2015 | 11.50M |
| June 30, 2015 | 13.09M |
| March 31, 2015 | 13.01M |
| December 31, 2014 | 12.42M |
| September 30, 2014 | 11.50M |
| June 30, 2014 | 11.75M |
| March 31, 2014 | 1.828M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 72.40M |
| Shareholders Equity (Quarterly) | -55.65M |